APO Research
Talk to an analyst

APO RESEARCH · REPORT

Devic's Disease Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Devic's Disease Drug Industry Growth and Trends Forecast to 2032

26 December 2025102 pages

Choose your research edition.

Industry ResearchDevic's Disease Drug Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Devic's Disease Drug Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Devic's Disease Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Devic's Disease Drug Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Devic's Disease Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Devic's Disease Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Devic's Disease Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Devic's Disease Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Devic's Disease Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Devic's Disease Drug include CBOP, CSL, Fresenius, Grifols, Gyjtrs, Intas, Nang Kuang, Octapharma and Tianjin Kingyork, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Devic's Disease Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Devic's Disease Drug market size, estimates, and forecasts are presented in terms of sales volume (K Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Devic's Disease Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Devic's Disease Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Devic's Disease Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Devic's Disease Drug Market by Company

CBOP

CSL

Fresenius

Grifols

Gyjtrs

Intas

Nang Kuang

Octapharma

Tianjin Kingyork

Baxter

Pfizer

Sandoz

TEVA

Devic's Disease Drug Segment by Type

Glucocorticoids

Immunoglobulin

Other

Devic's Disease Drug Segment by Application

Hospitals

Clinics

Others

Devic's Disease Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Devic's Disease Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Devic's Disease Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Devic's Disease Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Devic's Disease Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Devic's Disease Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Glucocorticoids Table 2. Major Company of Immunoglobulin Table 3. Major Company of Other Table 4. Global Devic's Disease Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Devic's Disease Drug Sales by Type (2021-2026) & (K Tons) Table 6. Global Devic's Disease Drug Sales Market Share in Volume by Type (2021-2026) Table 7. Global Devic's Disease Drug Sales by Type (2021-2026) & (US$ Million) Table 8. Global Devic's Disease Drug Sales Market Share in Value by Type (2021-2026) Table 9. Global Devic's Disease Drug Price by Type (2021-2026) & (US$/Ton) Table 10. Global Devic's Disease Drug Sales by Type (2027-2032) & (K Tons) Table 11. Global Devic's Disease Drug Sales Market Share in Volume by Type (2027-2032) Table 12. Global Devic's Disease Drug Sales by Type (2027-2032) & (US$ Million) Table 13. Global Devic's Disease Drug Sales Market Share in Value by Type (2027-2032) Table 14. Global Devic's Disease Drug Price by Type (2027-2032) & (US$/Ton) Table 15. North America Devic's Disease Drug Sales by Type (2021-2026) & (K Tons) Table 16. North America Devic's Disease Drug Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Devic's Disease Drug Sales by Type (2021-2026) & (K Tons) Table 18. Europe Devic's Disease Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Devic's Disease Drug Sales by Type (2021-2026) & (K Tons) Table 20. Asia-Pacific Devic's Disease Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Devic's Disease Drug Sales by Type (2021-2026) & (K Tons) Table 22. Latin America Devic's Disease Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Devic's Disease Drug Sales by Type (2021-2026) & (K Tons) Table 24. Middle East and Africa Devic's Disease Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Devic's Disease Drug Industry Trends Table 26. Devic's Disease Drug Industry Drivers Table 27. Devic's Disease Drug Industry Opportunities and Challenges Table 28. Devic's Disease Drug Industry Restraints Table 29. Global Devic's Disease Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Devic's Disease Drug Revenue Market Share by Company (2021-2026) Table 31. Global Devic's Disease Drug Sales by Company (2021-2026) & (K Tons) Table 32. Global Devic's Disease Drug Sales Share by Company (2021-2026) Table 33. Global Devic's Disease Drug Market Price by Company (2021-2026) & (US$/Ton) Table 34. Global Devic's Disease Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Devic's Disease Drug Major Company Production Sites and Headquarters Table 36. Global Devic's Disease Drug Company, Product Type & Application Table 37. Global Devic's Disease Drug Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Devic's Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Devic's Disease Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Devic's Disease Drug Sales by Region (2021-2026) & (K Tons) Table 42. Global Devic's Disease Drug Sales Market Share in Volume by Region (2021-2026) Table 43. Global Devic's Disease Drug Sales by Region (2021-2026) & (US$ Million) Table 44. Global Devic's Disease Drug Sales Market Share in Value by Region (2021-2026) Table 45. Global Devic's Disease Drug Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 46. Global Devic's Disease Drug Sales by Region (2027-2032) & (K Tons) Table 47. Global Devic's Disease Drug Sales Market Share in Volume by Region (2027-2032) Table 48. Global Devic's Disease Drug Sales by Region (2027-2032) & (US$ Million) Table 49. Global Devic's Disease Drug Sales Market Share in Value by Region (2027-2032) Table 50. Global Devic's Disease Drug Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 51. Global Devic's Disease Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Devic's Disease Drug Sales by Application (2021-2026) & (K Tons) Table 53. Global Devic's Disease Drug Sales Market Share in Volume by Application (2021-2026) Table 54. Global Devic's Disease Drug Sales by Application (2021-2026) & (US$ Million) Table 55. Global Devic's Disease Drug Sales Market Share in Value by Application (2021-2026) Table 56. Global Devic's Disease Drug Price by Application (2021-2026) & (US$/Ton) Table 57. Global Devic's Disease Drug Sales by Application (2027-2032) & (K Tons) Table 58. Global Devic's Disease Drug Sales Market Share in Volume by Application (2027-2032) Table 59. Global Devic's Disease Drug Sales by Application (2027-2032) & (US$ Million) Table 60. Global Devic's Disease Drug Sales Market Share in Value by Application (2027-2032) Table 61. Global Devic's Disease Drug Price by Application (2027-2032) & (US$/Ton) Table 62. North America Devic's Disease Drug Sales by Application (2021-2026) & (K Tons) Table 63. North America Devic's Disease Drug Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Devic's Disease Drug Sales by Application (2021-2026) & (K Tons) Table 65. Europe Devic's Disease Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Devic's Disease Drug Sales by Application (2021-2026) & (K Tons) Table 67. Asia-Pacific Devic's Disease Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Devic's Disease Drug Sales by Application (2021-2026) & (K Tons) Table 69. Latin America Devic's Disease Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Devic's Disease Drug Sales by Application (2021-2026) & (K Tons) Table 71. Middle East and Africa Devic's Disease Drug Sales by Application (2021-2026) & (US$ Million) Table 72. CBOP Company Information Table 73. CBOP Business Overview Table 74. CBOP Devic's Disease Drug Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. CBOP Devic's Disease Drug Product Portfolio Table 76. CBOP Recent Development Table 77. CSL Company Information Table 78. CSL Business Overview Table 79. CSL Devic's Disease Drug Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. CSL Devic's Disease Drug Product Portfolio Table 81. CSL Recent Development Table 82. Fresenius Company Information Table 83. Fresenius Business Overview Table 84. Fresenius Devic's Disease Drug Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. Fresenius Devic's Disease Drug Product Portfolio Table 86. Fresenius Recent Development Table 87. Grifols Company Information Table 88. Grifols Business Overview Table 89. Grifols Devic's Disease Drug Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. Grifols Devic's Disease Drug Product Portfolio Table 91. Grifols Recent Development Table 92. Gyjtrs Company Information Table 93. Gyjtrs Business Overview Table 94. Gyjtrs Devic's Disease Drug Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 95. Gyjtrs Devic's Disease Drug Product Portfolio Table 96. Gyjtrs Recent Development Table 97. Intas Company Information Table 98. Intas Business Overview Table 99. Intas Devic's Disease Drug Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 100. Intas Devic's Disease Drug Product Portfolio Table 101. Intas Recent Development Table 102. Nang Kuang Company Information Table 103. Nang Kuang Business Overview Table 104. Nang Kuang Devic's Disease Drug Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 105. Nang Kuang Devic's Disease Drug Product Portfolio Table 106. Nang Kuang Recent Development Table 107. Octapharma Company Information Table 108. Octapharma Business Overview Table 109. Octapharma Devic's Disease Drug Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 110. Octapharma Devic's Disease Drug Product Portfolio Table 111. Octapharma Recent Development Table 112. Tianjin Kingyork Company Information Table 113. Tianjin Kingyork Business Overview Table 114. Tianjin Kingyork Devic's Disease Drug Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 115. Tianjin Kingyork Devic's Disease Drug Product Portfolio Table 116. Tianjin Kingyork Recent Development Table 117. Baxter Company Information Table 118. Baxter Business Overview Table 119. Baxter Devic's Disease Drug Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 120. Baxter Devic's Disease Drug Product Portfolio Table 121. Baxter Recent Development Table 122. Pfizer Company Information Table 123. Pfizer Business Overview Table 124. Pfizer Devic's Disease Drug Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 125. Pfizer Devic's Disease Drug Product Portfolio Table 126. Pfizer Recent Development Table 127. Sandoz Company Information Table 128. Sandoz Business Overview Table 129. Sandoz Devic's Disease Drug Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 130. Sandoz Devic's Disease Drug Product Portfolio Table 131. Sandoz Recent Development Table 132. TEVA Company Information Table 133. TEVA Business Overview Table 134. TEVA Devic's Disease Drug Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 135. TEVA Devic's Disease Drug Product Portfolio Table 136. TEVA Recent Development Table 137. North America Devic's Disease Drug Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 138. North America Devic's Disease Drug Sales by Country (2021-2026) & (K Tons) Table 139. North America Devic's Disease Drug Sales Market Share by Country (2021-2026) Table 140. North America Devic's Disease Drug Sales Forecast by Country (2027-2032) & (K Tons) Table 141. North America Devic's Disease Drug Sales Market Share Forecast by Country (2027-2032) Table 142. North America Devic's Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. North America Devic's Disease Drug Market Size by Country (2021-2026) & (US$ Million) Table 144. North America Devic's Disease Drug Market Share by Country (2021-2026) Table 145. North America Devic's Disease Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. North America Devic's Disease Drug Market Share Forecast by Country (2027-2032) Table 147. Europe Devic's Disease Drug Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 148. Europe Devic's Disease Drug Sales by Country (2021-2026) & (K Tons) Table 149. Europe Devic's Disease Drug Sales Market Share by Country (2021-2026) Table 150. Europe Devic's Disease Drug Sales Forecast by Country (2027-2032) & (K Tons) Table 151. Europe Devic's Disease Drug Sales Market Share Forecast by Country (2027-2032) Table 152. Europe Devic's Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Europe Devic's Disease Drug Market Size by Country (2021-2026) & (US$ Million) Table 154. Europe Devic's Disease Drug Market Share by Country (2021-2026) Table 155. Europe Devic's Disease Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Europe Devic's Disease Drug Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Devic's Disease Drug Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Devic's Disease Drug Sales by Country (2021-2026) & (K Tons) Table 159. Asia-Pacific Devic's Disease Drug Sales Market Share by Country (2021-2026) Table 160. Asia-Pacific Devic's Disease Drug Sales Forecast by Country (2027-2032) & (K Tons) Table 161. Asia-Pacific Devic's Disease Drug Sales Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Devic's Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Devic's Disease Drug Market Size by Country (2021-2026) & (US$ Million) Table 164. Asia-Pacific Devic's Disease Drug Market Share by Country (2021-2026) Table 165. Asia-Pacific Devic's Disease Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Asia-Pacific Devic's Disease Drug Market Share Forecast by Country (2027-2032) Table 167. Latin America Devic's Disease Drug Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 168. Latin America Devic's Disease Drug Sales by Country (2021-2026) & (K Tons) Table 169. Latin America Devic's Disease Drug Sales Market Share by Country (2021-2026) Table 170. Latin America Devic's Disease Drug Sales Forecast by Country (2027-2032) & (K Tons) Table 171. Latin America Devic's Disease Drug Sales Market Share Forecast by Country (2027-2032) Table 172. Latin America Devic's Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Latin America Devic's Disease Drug Market Size by Country (2021-2026) & (US$ Million) Table 174. Latin America Devic's Disease Drug Market Share by Country (2021-2026) Table 175. Latin America Devic's Disease Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Latin America Devic's Disease Drug Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Devic's Disease Drug Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Devic's Disease Drug Sales by Country (2021-2026) & (K Tons) Table 179. Middle East and Africa Devic's Disease Drug Sales Market Share by Country (2021-2026) Table 180. Middle East and Africa Devic's Disease Drug Sales Forecast by Country (2027-2032) & (K Tons) Table 181. Middle East and Africa Devic's Disease Drug Sales Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Devic's Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Devic's Disease Drug Market Size by Country (2021-2026) & (US$ Million) Table 184. Middle East and Africa Devic's Disease Drug Market Share by Country (2021-2026) Table 185. Middle East and Africa Devic's Disease Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Middle East and Africa Devic's Disease Drug Market Share Forecast by Country (2027-2032) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Devic's Disease Drug Distributors List Table 190. Devic's Disease Drug Customers List Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. Devic's Disease Drug Image Figure 2. Global Devic's Disease Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Devic's Disease Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Devic's Disease Drug Sales (2021-2032) & (K Tons) Figure 5. Glucocorticoids Image Figure 6. Global Glucocorticoids Sales YoY Growth (2021-2032) & (K Tons) Figure 7. Immunoglobulin Image Figure 8. Global Immunoglobulin Sales YoY Growth (2021-2032) & (K Tons) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Tons) Figure 11. Global Devic's Disease Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Devic's Disease Drug Market Share by Type 2025 VS 2032 Figure 13. North America Devic's Disease Drug Sales Market Share in Volume by Type in 2025 Figure 14. North America Devic's Disease Drug Sales Market Share in Value by Type in 2025 Figure 15. Europe Devic's Disease Drug Sales Market Share in Volume by Type in 2025 Figure 16. Europe Devic's Disease Drug Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Devic's Disease Drug Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Devic's Disease Drug Sales Market Share in Value by Type in 2025 Figure 19. Latin America Devic's Disease Drug Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Devic's Disease Drug Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Devic's Disease Drug Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Devic's Disease Drug Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Devic's Disease Drug Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospitals Image Figure 26. Global Hospitals Sales YoY Growth (2021-2032) & (K Tons) Figure 27. Clinics Image Figure 28. Global Clinics Sales YoY Growth (2021-2032) & (K Tons) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Tons) Figure 31. Global Devic's Disease Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Devic's Disease Drug Market Share by Application 2025 VS 2032 Figure 33. North America Devic's Disease Drug Sales Market Share in Volume by Application in 2025 Figure 34. North America Devic's Disease Drug Sales Market Share in Value by Application in 2025 Figure 35. Europe Devic's Disease Drug Sales Market Share in Volume by Application in 2025 Figure 36. Europe Devic's Disease Drug Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Devic's Disease Drug Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Devic's Disease Drug Sales Market Share in Value by Application in 2025 Figure 39. Latin America Devic's Disease Drug Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Devic's Disease Drug Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Devic's Disease Drug Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Devic's Disease Drug Sales Market Share in Value by Application in 2025 Figure 43. North America Devic's Disease Drug Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 44. North America Devic's Disease Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Devic's Disease Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Devic's Disease Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Devic's Disease Drug Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 48. Europe Devic's Disease Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Devic's Disease Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Devic's Disease Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Devic's Disease Drug Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 52. Asia-Pacific Devic's Disease Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Devic's Disease Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Devic's Disease Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Devic's Disease Drug Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 56. Latin America Devic's Disease Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Devic's Disease Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Devic's Disease Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Devic's Disease Drug Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 60. Middle East and Africa Devic's Disease Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Devic's Disease Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Devic's Disease Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Devic's Disease Drug Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Devic's Disease Drug Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Glucocorticoids
  • Immunoglobulin
  • Other
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • CBOP
  • CSL
  • Fresenius
  • Grifols
  • Gyjtrs
  • Intas
  • Nang Kuang
  • Octapharma
  • Tianjin Kingyork
  • Baxter
  • Pfizer
  • Sandoz
  • TEVA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Devic's Disease Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Devic's Disease Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Devic's Disease Drug Market by Type
  6. 1.3.1 Glucocorticoids
  7. 1.3.2 Immunoglobulin
  8. 1.3.3 Other
  9. 1.4 Global Devic's Disease Drug Market Size by Type
  10. 1.4.1 Global Devic's Disease Drug Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Devic's Disease Drug Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Devic's Disease Drug Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Devic's Disease Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Devic's Disease Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Devic's Disease Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Devic's Disease Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Devic's Disease Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Devic's Disease Drug Industry Trends
  2. 2.2 Devic's Disease Drug Industry Drivers
  3. 2.3 Devic's Disease Drug Industry Opportunities and Challenges
  4. 2.4 Devic's Disease Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Devic's Disease Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Devic's Disease Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Devic's Disease Drug Price (2021-2026)
  4. 3.4 Global Devic's Disease Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Devic's Disease Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Devic's Disease Drug Company, Product Type & Application
  7. 3.7 Global Devic's Disease Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Devic's Disease Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Devic's Disease Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Devic's Disease Drug Tier 1, Tier 2, and Tier 3
4 Devic's Disease Drug Regional Status and Outlook
  1. 4.1 Global Devic's Disease Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Devic's Disease Drug Historic Market Size by Region
  3. 4.2.1 Global Devic's Disease Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Devic's Disease Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Devic's Disease Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Devic's Disease Drug Forecasted Market Size by Region
  7. 4.3.1 Global Devic's Disease Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Devic's Disease Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Devic's Disease Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Devic's Disease Drug by Application
  1. 5.1 Devic's Disease Drug Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Devic's Disease Drug Market Size by Application
  6. 5.2.1 Global Devic's Disease Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Devic's Disease Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Devic's Disease Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Devic's Disease Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Devic's Disease Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Devic's Disease Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Devic's Disease Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Devic's Disease Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CBOP
  2. 6.1.1 CBOP Company Information
  3. 6.1.2 CBOP Business Overview
  4. 6.1.3 CBOP Devic's Disease Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CBOP Devic's Disease Drug Product Portfolio
  6. 6.1.5 CBOP Recent Developments
  7. 6.2 CSL
  8. 6.2.1 CSL Company Information
  9. 6.2.2 CSL Business Overview
  10. 6.2.3 CSL Devic's Disease Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CSL Devic's Disease Drug Product Portfolio
  12. 6.2.5 CSL Recent Developments
  13. 6.3 Fresenius
  14. 6.3.1 Fresenius Company Information
  15. 6.3.2 Fresenius Business Overview
  16. 6.3.3 Fresenius Devic's Disease Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Fresenius Devic's Disease Drug Product Portfolio
  18. 6.3.5 Fresenius Recent Developments
  19. 6.4 Grifols
  20. 6.4.1 Grifols Company Information
  21. 6.4.2 Grifols Business Overview
  22. 6.4.3 Grifols Devic's Disease Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Grifols Devic's Disease Drug Product Portfolio
  24. 6.4.5 Grifols Recent Developments
  25. 6.5 Gyjtrs
  26. 6.5.1 Gyjtrs Company Information
  27. 6.5.2 Gyjtrs Business Overview
  28. 6.5.3 Gyjtrs Devic's Disease Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Gyjtrs Devic's Disease Drug Product Portfolio
  30. 6.5.5 Gyjtrs Recent Developments
  31. 6.6 Intas
  32. 6.6.1 Intas Company Information
  33. 6.6.2 Intas Business Overview
  34. 6.6.3 Intas Devic's Disease Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Intas Devic's Disease Drug Product Portfolio
  36. 6.6.5 Intas Recent Developments
  37. 6.7 Nang Kuang
  38. 6.7.1 Nang Kuang Company Information
  39. 6.7.2 Nang Kuang Business Overview
  40. 6.7.3 Nang Kuang Devic's Disease Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Nang Kuang Devic's Disease Drug Product Portfolio
  42. 6.7.5 Nang Kuang Recent Developments
  43. 6.8 Octapharma
  44. 6.8.1 Octapharma Company Information
  45. 6.8.2 Octapharma Business Overview
  46. 6.8.3 Octapharma Devic's Disease Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Octapharma Devic's Disease Drug Product Portfolio
  48. 6.8.5 Octapharma Recent Developments
  49. 6.9 Tianjin Kingyork
  50. 6.9.1 Tianjin Kingyork Company Information
  51. 6.9.2 Tianjin Kingyork Business Overview
  52. 6.9.3 Tianjin Kingyork Devic's Disease Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Tianjin Kingyork Devic's Disease Drug Product Portfolio
  54. 6.9.5 Tianjin Kingyork Recent Developments
  55. 6.10 Baxter
  56. 6.10.1 Baxter Company Information
  57. 6.10.2 Baxter Business Overview
  58. 6.10.3 Baxter Devic's Disease Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Baxter Devic's Disease Drug Product Portfolio
  60. 6.10.5 Baxter Recent Developments
  61. 6.11 Pfizer
  62. 6.11.1 Pfizer Company Information
  63. 6.11.2 Pfizer Business Overview
  64. 6.11.3 Pfizer Devic's Disease Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Pfizer Devic's Disease Drug Product Portfolio
  66. 6.11.5 Pfizer Recent Developments
  67. 6.12 Sandoz
  68. 6.12.1 Sandoz Company Information
  69. 6.12.2 Sandoz Business Overview
  70. 6.12.3 Sandoz Devic's Disease Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Sandoz Devic's Disease Drug Product Portfolio
  72. 6.12.5 Sandoz Recent Developments
  73. 6.13 TEVA
  74. 6.13.1 TEVA Company Information
  75. 6.13.2 TEVA Business Overview
  76. 6.13.3 TEVA Devic's Disease Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 TEVA Devic's Disease Drug Product Portfolio
  78. 6.13.5 TEVA Recent Developments
7 North America by Country
  1. 7.1 North America Devic's Disease Drug Sales by Country
  2. 7.1.1 North America Devic's Disease Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Devic's Disease Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Devic's Disease Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Devic's Disease Drug Market Size by Country
  6. 7.2.1 North America Devic's Disease Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Devic's Disease Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Devic's Disease Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Devic's Disease Drug Sales by Country
  2. 8.1.1 Europe Devic's Disease Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Devic's Disease Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Devic's Disease Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Devic's Disease Drug Market Size by Country
  6. 8.2.1 Europe Devic's Disease Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Devic's Disease Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Devic's Disease Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Devic's Disease Drug Sales by Country
  2. 9.1.1 Asia-Pacific Devic's Disease Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Devic's Disease Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Devic's Disease Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Devic's Disease Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Devic's Disease Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Devic's Disease Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Devic's Disease Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Devic's Disease Drug Sales by Country
  2. 10.1.1 South America Devic's Disease Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Devic's Disease Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Devic's Disease Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Devic's Disease Drug Market Size by Country
  6. 10.2.1 South America Devic's Disease Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Devic's Disease Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Devic's Disease Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Devic's Disease Drug Sales by Country
  2. 11.1.1 Middle East and Africa Devic's Disease Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Devic's Disease Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Devic's Disease Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Devic's Disease Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Devic's Disease Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Devic's Disease Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Devic's Disease Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Devic's Disease Drug Value Chain Analysis
  2. 12.1.1 Devic's Disease Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Devic's Disease Drug Production Mode & Process
  7. 12.2 Devic's Disease Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Devic's Disease Drug Distributors
  10. 12.2.3 Devic's Disease Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst